-
Uncategorized2 weeks ago
Process intensification: Separating fact from fiction
Uncover four key misconceptions that could be holding your intensification strategies back — and how to set your initiatives up for success. Read More
-
Uncategorized2 weeks agoOpinion: 8 former CDC directors: Reform PEPFAR, don’t dismantle it
On Sunday, the World Health Organization (WHO) declared an Ebola outbreak in the Democratic Republic of the Congo and Uganda to be a public health emergency....
-
Uncategorized2 weeks ago
All eyes on Revolution, bispecific antibodies and more at ASCO26
Partners Summit Therapeutics and Akeso are expected to steal the show at the American Society of Clinical Oncology’s annual conference with data from their potential Keytruda...
-
Uncategorized2 weeks ago
4 troubled targets that have thwarted biopharma
4 troubled targets that have thwarted biopharma
-
Uncategorized2 weeks ago
REGENXBIO, Novartis, Dyne near FDA submissions in muscular dystrophies
Analysts homed in on Duchenne muscular dystrophy and myotonic dystrophy type 1 assets during first quarter earnings as major players like REGENXBIO and Novartis as well...
-
Uncategorized2 weeks ago
Author Correction: DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage
Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03180-7 Author Correction: DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage
-
Uncategorized3 weeks agoSTAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial, an early but...
-
Uncategorized3 weeks agoFirst patients dosed in hypertrophic cardiomyopathy trial
HAYA Therapeutics has dosed the first cohort in a Phase I trial evaluating a treatment for nonobstructive hypertrophic cardiomyopathy (nHCM). The Swiss biotechnology company is studying...
-
Uncategorized3 weeks agoOpinion: How the perimenopause movement is hurting women
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Patricia Bencivenga and Adriane Fugh-Berman. Be sure to sign up for the...
-
Uncategorized3 weeks ago
Inside Makary’s ouster; Another win for Lilly’s triple-G; and more
Welcome back to another edition of Endpoints Weekly! My usual co-author Nicole DeFeudis was out this week on a much-deserved vacation, so I’m instead joined by...
STAT+: At hospital finance conference, a call to end the friction that’s keeping costs high
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
